Synfacts, Table of Contents Synfacts 2023; 19(03): 0304DOI: 10.1055/s-0042-1752401 Innovative Drug Discovery and Development Small Molecule SST2 Agonist as a Potential Therapeutic for Acromegaly and Neuroendocrine TumorsContributor(s): Antonia F. Stepan (Roche) , Nadine Kuhl (MSD) , Danica A. Rankic (Pfizer)Recommend Article Abstract Buy ArticleKey words Key wordssomatostatin - paltusotine - SST2 agonist - acromegaly - neuroendocrine tumors - Suzuki coupling Full Text